Back to search

Article

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2

2020-07-25

Abstract excerpt

Perfusion of convalescent plasma (CP) has demonstrated a potential to improve the pneumonia induced by SARS-CoV-2, but procurement and standardization of CP are barriers to its wide usage. Many monoclonal antibodies (mAbs) have been developed but appear insufficient to neutralize SARS-CoV-2 unless two or three of them are being combined. Therefore, heterologous polyclonal antibodies of animal origin, that have bee...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3ec8e56d-032b-53dd-be60-c225675b9bf2
DOI
10.1101/2020.07.25.217158
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2DOI 10.1101/2020.07.25.217158
Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variantsSemantic proximity
XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variantsSemantic proximity
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 miceSemantic proximity
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)Semantic proximity
A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection modelSemantic proximity
Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheepSemantic proximity
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinSemantic proximity
Broad cross-neutralizing antibodies against animal-associated sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humansSemantic proximity
Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovinesSemantic proximity
Fully Human Antibody Immunoglobulin from Transchromosomic Bovines is Potent Against SARS-CoV-2 Variant PseudovirusesSemantic proximity
Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigsSemantic proximity
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in pigletsSemantic proximity
Select a neighboring publication to make it the new centre.